Cargando…
Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields
Mutations and the glycosylation of epitopes can convert immunogenic epitopes into non-immunogenic ones via natural selection or evolutionary pressure, thereby decreasing their sensitivity to neutralizing antibodies. Based on Thomas Francis’s theory, memory B and T cells induced during primary infect...
Autores principales: | Baghaie, Leili, Leroy, Fleur, Sheikhi, Mehdi, Jafarzadeh, Abdollah, Szewczuk, Myron R., Sheikhi, Abdolkarim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612084/ https://www.ncbi.nlm.nih.gov/pubmed/37896856 http://dx.doi.org/10.3390/v15102079 |
Ejemplares similares
-
Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential
por: Moshe, Daniel Leon, et al.
Publicado: (2023) -
The HIV glycan shield as a target for broadly neutralizing antibodies
por: Doores, Katie J.
Publicado: (2015) -
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
por: Lavie, Muriel, et al.
Publicado: (2018) -
Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms
por: Ghaffari, Seyed Ali, et al.
Publicado: (2017) -
Insulin Receptor Signaling in Health and Disease
por: Baghaie, Leili, et al.
Publicado: (2023)